Macquarie Group Ltd. Sells 5,436 Shares of UnitedHealth Group Inc (UNH)

Macquarie Group Ltd. reduced its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 342,355 shares of the healthcare conglomerate’s stock after selling 5,436 shares during the quarter. Macquarie Group Ltd.’s holdings in UnitedHealth Group were worth $67,051,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Jennison Associates LLC grew its holdings in shares of UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after buying an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC grew its holdings in shares of UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after buying an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after buying an additional 1,588,516 shares in the last quarter. Parametric Portfolio Associates LLC grew its holdings in shares of UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after buying an additional 1,562,661 shares in the last quarter. Finally, Thrivent Financial For Lutherans grew its holdings in shares of UnitedHealth Group by 346.7% during the second quarter. Thrivent Financial For Lutherans now owns 1,690,187 shares of the healthcare conglomerate’s stock worth $313,394,000 after buying an additional 1,311,773 shares in the last quarter. Hedge funds and other institutional investors own 86.09% of the company’s stock.

A number of brokerages have recently commented on UNH. Argus lifted their price target on shares of UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a report on Thursday. Credit Suisse Group lifted their price target on shares of UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a report on Wednesday. Oppenheimer lifted their price target on shares of UnitedHealth Group from $260.00 to $240.00 and gave the stock an “outperform” rating in a report on Wednesday. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group to $280.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Deutsche Bank lifted their price target on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $241.30.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Michele J. Hooper sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the transaction, the director now directly owns 36,989 shares in the company, valued at $8,218,955.80. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,655 shares of company stock worth $7,469,083. 0.89% of the stock is currently owned by corporate insiders.

UnitedHealth Group Inc (UNH) opened at $243.16 on Friday. The firm has a market cap of $231,054.77, a P/E ratio of 23.65, a price-to-earnings-growth ratio of 1.45 and a beta of 0.66. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73. UnitedHealth Group Inc has a 12-month low of $156.49 and a 12-month high of $243.90.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. UnitedHealth Group’s revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company posted $2.11 earnings per share. equities research analysts predict that UnitedHealth Group Inc will post 12.2 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Macquarie Group Ltd. Sells 5,436 Shares of UnitedHealth Group Inc (UNH)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/19/macquarie-group-ltd-sells-5436-shares-of-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply